Skip to Main Content

Paper Details

Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma.
Cell Discov
3
2022
BCL2, BRAF, BRAF melanoma, E2F, cancer, cancers, cells, chromosome 18q21, drug-tolerant persister cells, heterogeneous clones, lineage-coupled resistant cells, melanoma, resistant clones, tumors, vemurafenib
Author NameAffiliation
Ravesanker EzhilarasanNew York University (NYU) Grossman School of Medicine
Ravesanker EzhilarasanLaura and Isaac Perlmutter Cancer Center
Qianghu WangNanjing Medical University
Qianghu WangInstitute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University
Qianghu WangCollaborative Innovation Center for Cardiovascular Disease Translational Medicine
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
Roel G W Verhaak
Roel G W Verhaak
Erik P SulmanNew York University (NYU) Grossman School of Medicine
Erik P SulmanLaura and Isaac Perlmutter Cancer Center
Erik P SulmanNew York University (NYU) Grossman School of Medicine
Erik P SulmanLaura and Isaac Perlmutter Cancer Center
  • 1 - 12

Datasets

Release 1.2